Anti-MAGEA10 monoclonal antibody

Pre-made anti-MAGEA10 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to MAGEA10/MAGEA10 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-INN008-Ab-1/ GM-Tg-hg-INN008-Ab-2Anti-Human MAGEA10 monoclonal antibodyHuman
GM-Tg-rg-INN008-Ab-1/ GM-Tg-rg-INN008-Ab-2Anti-Rat MAGEA10 monoclonal antibodyRat
GM-Tg-mg-INN008-Ab-1/ GM-Tg-mg-INN008-Ab-2Anti-Mouse MAGEA10 monoclonal antibodyMouse
GM-Tg-cynog-INN008-Ab-1/ GM-Tg-cynog-INN008-Ab-2Anti-Cynomolgus/ Rhesus macaque MAGEA10 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-INN008-Ab-1/ GM-Tg-felg-INN008-Ab-2Anti-Feline MAGEA10 monoclonal antibodyFeline
GM-Tg-cang-INN008-Ab-1/ GM-Tg-cang-INN008-Ab-2Anti-Canine MAGEA10 monoclonal antibodyCanine
GM-Tg-bovg-INN008-Ab-1/ GM-Tg-bovg-INN008-Ab-2Anti-Bovine MAGEA10 monoclonal antibodyBovine
GM-Tg-equg-INN008-Ab-1/ GM-Tg-equg-INN008-Ab-2Anti-Equine MAGEA10 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-INN008-Ab-1/ GM-Tg-hg-INN008-Ab-2; GM-Tg-rg-INN008-Ab-1/ GM-Tg-rg-INN008-Ab-2;
GM-Tg-mg-INN008-Ab-1/ GM-Tg-mg-INN008-Ab-2; GM-Tg-cynog-INN008-Ab-1/ GM-Tg-cynog-INN008-Ab-2;
GM-Tg-felg-INN008-Ab-1/ GM-Tg-felg-INN008-Ab-2; GM-Tg-cang-INN008-Ab-1/ GM-Tg-cang-INN008-Ab-2;
GM-Tg-bovg-INN008-Ab-1/ GM-Tg-bovg-INN008-Ab-2; GM-Tg-equg-INN008-Ab-1/ GM-Tg-equg-INN008-Ab-2
Products NameAnti-MAGEA10 monoclonal antibody
Formatmab
Target NameMAGEA10
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-MAGEA10 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-INN008-Ag-1Recombinant multi-species MAGAA/ MAGEA10/ CT1.10 protein


    Target information

    Target IDGM-INN008
    Target NameMAGEA10
    Gene ID4109,236852,711149
    Gene Symbol and SynonymsCT1.10,MAGE10,MAGEA10
    Uniprot AccessionP43363
    Uniprot Entry NameMAGAA_HUMAN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target, Immuno-oncology Target, INN Index
    DiseaseN/A
    Gene EnsemblENSG00000124260
    Target ClassificationCheckpoint-Immuno Oncology

    The target: MAGEA10, gene name: MAGEA10, also named as CT1.10, MAGE10. This gene is a member of the MAGEA gene family. The members of this family encode proteins with 50 to 80% sequence identity to each other. The promoters and first exons of the MAGEA genes show considerable variability, suggesting that the existence of this gene family enables the same function to be expressed under different transcriptional controls. The MAGEA genes are clustered at chromosomal location Xq28. They have been implicated in some hereditary disorders, such as dyskeratosis congenita. Alternative splicing results in multiple transcript variants. Read-through transcription also exists between this gene and the downstream melanoma antigen family A, 5 (MAGEA5) gene.[provided by RefSeq, Oct 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.